Daily BriefsHealthcare

Health Care: Alfresa Holdings and more

In today’s briefing:

  • Alfresa Holdings (2784 JP): Looking Ahead Through 2022–25 Mid-Term Management Plan

Alfresa Holdings (2784 JP): Looking Ahead Through 2022–25 Mid-Term Management Plan

By Tina Banerjee

  • Alfresa Holdings (2784 JP) reported revenue decline in FY21. Apart from market wide negative impact of COVID-19 and drug price revision, suspended qualification for public bidding tenders affected the company.
  • In FY22, the company is expected to be back to its growth path with less impact of bidding suspension and increasing focus on high growth areas.
  • According to its 2022–2024 mid-term management plan, Alfresa targets to achieve a revenue of ¥2.7 trillion and operating income margin of 1.5% or higher by FY25.

Before it’s here, it’s on Smartkarma